3.0
Feb 2, 2014
GSK is a great company with surprisingly untapped potential.
Former employee, more than 1 year
Petaling Jaya
Recommend
CEO approval
Business Outlook
Pros
As its visionary CEO, Andrew Witty has clearly initiated many imminent changes over the past few years to ensure the company will remain competitive and relevant in the uncertain future of the Big Pharmas. The company certainly has the unique advantage to leverage on its businesses and transform the archaic way the industry is somehow still refusing to let go.
Cons
The local company has very little context or knowledge of the pharma industry and market. This situation is made worse when the management team are mainly foreigners and the local team are not capable to provide that valuable external insights to manage that knowledge gap. When the leaders are weak, and the subordinates are mere followers, there isn't much to look forward to.
